Clinical Trial Update: Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing raltegravir with lopinavir/ritonavir versus efavirenz-based regimen in treatment-naive HIV patients; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Efavirenz + Tenofovir + Emtricitabine
• Raltegravir + Lopinavir/Ritonavir

Snippet

Sponsor: University of California, San Diego | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2020-07-07